Ignite Creation Date:
2024-05-05 @ 7:11 PM
Last Modification Date:
2024-10-26 @ 9:45 AM
Study NCT ID:
NCT00620048
Status:
TERMINATED
Last Update Posted:
2015-03-31
First Post:
2008-02-07
Brief Title:
Stem Cell Study for Subjects With Congestive Heart Failure
Sponsor:
Losordo Douglas MD
Organization:
Losordo Douglas MD
Study Overview
Official Title:
Injection of Autologous CD34 Cells for Neovascularization and Symptom Relief in Patients With Myocardial Ischemia and LVEF 40
Status:
TERMINATED
Status Verified Date:
2011-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Study terminated due to lack of funding
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine if cell therapy with your own cells autologous cells delivered with a catheter to regions of the heart with poor blood flow will be safe and if it will improve your ejection fraction and heart failure symptoms
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 11196-03 | OTHER | Sponsor protocol number | None |